Diabetic complications do not hamper improvement of health-related quality of life over the course of treatment of diabetic foot ulcers - the Eurodiale study
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, multicentrická studie, pozorovací studie
PubMed
28457703
DOI
10.1016/j.jdiacomp.2017.04.008
PII: S1056-8727(16)31096-0
Knihovny.cz E-zdroje
- Klíčová slova
- Comorbidity, Diabetes mellitus, Diabetic foot ulcer, Health-related quality of life, Longitudinal study,
- MeSH
- činnosti denního života * MeSH
- deprese epidemiologie MeSH
- diabetická noha epidemiologie psychologie terapie MeSH
- hojení ran MeSH
- kohortové studie MeSH
- kombinovaná terapie škodlivé účinky MeSH
- komorbidita MeSH
- komplikace diabetu epidemiologie psychologie terapie MeSH
- kvalita života * MeSH
- lidé středního věku MeSH
- lidé MeSH
- longitudinální studie MeSH
- osobní újma zaviněná nemocí * MeSH
- prospektivní studie MeSH
- psychiatrické posuzovací škály MeSH
- self-management MeSH
- senioři MeSH
- úzkost epidemiologie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- pozorovací studie MeSH
- Geografické názvy
- Evropa epidemiologie MeSH
AIMS: Diabetic complications, and in particular diabetic foot ulcers (DFUs), are associated with low health-related quality of life (HRQoL). We evaluated whether the presence of diabetic complications also influenced the improvement of HRQoL during DFU treatment. METHODS: 1088 patients presenting for DFU treatment at the centers participating in the Eurodiale study were followed prospectively up to one year. HRQoL was measured both at presentation and after healing or at end of follow up, using EQ-5D: a standardized instrument consisting of five domains and a summary index. The influence of diabetic comorbidity on the course of HRQoL was evaluated for each of the EQ-5D outcomes in multi-level linear regression analyses, adjusting for baseline characteristics. RESULTS: HRQoL improved in all EQ-5D outcomes over the course of treatment for those DFUs that healed. The few significant differences in the development of HRQoL between patients with and without comorbidity showed a more beneficial development for patients with comorbidity in DFUs that did not heal or healed slowly. CONCLUSIONS: Comorbidity does not hamper improvement of HRQoL in DFU treatment. On the contrary, HRQoL improved sometimes more in patients with certain comorbidity with hard-to-heal ulcers.
Department of Endocrinology University Medical Centre Ljubljana Slovenia
Department of Endocrinology University of Malmö Malmö Sweden
Department of Surgery Twenteborg Ziekenhuis Almelo The Netherlands
Diabetes Centre Institute for Clinical and Experimental Medicine Prague Czech Republic
Diabetes Centre Tameside General Hospital Ashton under Lyne UK
Diabetic Department Kings College Hospital London UK
Innere Abteilung Mariannen Hospital Werl Germany
Mathias Spital Diabetic Department Rheine Germany
Policlinico Tor Vergata Department of Internal Medicine Rome Italy
Citace poskytuje Crossref.org